Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015 – Free PDF | Print | Web
A short guide to fast language learning
Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Can J Gastroenterol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    January 2014
  1. SHUKLA T, Jin J, Marginean EC, Saloojee N, et al
    Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate.
    Can J Gastroenterol. 2014;28:11-2.
    PubMed     Text format    


    October 2013
  2. SIGALET DL , Kravarusic D, Butzner D, Hartmann B, et al
    A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients.
    Can J Gastroenterol. 2013;27:587-592.
    PubMed     Text format     Abstract available


  3. DEVLIN SM , Bressler B, Bernstein CN, Fedorak RN, et al
    Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics.
    Can J Gastroenterol. 2013;27:567-571.
    PubMed     Text format    


    August 2013
  4. JAMIESON DH , Shipman P, Jacobson K
    Magnetic resonance imaging of the perineum in pediatric patients with inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:476-80.
    PubMed     Text format     Abstract available


    April 2013
  5. SOON IS , Debruyn JC, Wrobel I
    Immunizatiion history of children with inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:213-6.
    PubMed     Text format     Abstract available


  6. STOLWIJK C , Pierik M, Landewe R, Masclee A, et al
    Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:199-205.
    PubMed     Text format     Abstract available


  7. GHOSH S
    Multidisciplinary teams as standard of care in inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:198.
    PubMed     Text format    


    March 2013
  8. WELLS M , Stecho W, Wehrli B, Khanna N, et al
    Sweet syndrome secondary to inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:124-5.
    PubMed     Text format    


    January 2013
  9. CHISICK L , Oleschuk C, Bernstein CN
    The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease.
    Can J Gastroenterol. 2013;27:39-43.
    PubMed     Text format     Abstract available


    December 2012
  10. ROSENFELD GA , Freeman H, Brown M, Steinbrecher UP, et al
    Severe and extensive enteritis following colectomy for ulcerative colitis.
    Can J Gastroenterol. 2012;26:866-7.
    PubMed     Text format    


  11. KELLERMAYER R
    Epigenetics and the developmental origins of inflammatory bowel diseases.
    Can J Gastroenterol. 2012;26:909-15.
    PubMed     Text format     Abstract available


    November 2012
  12. ROCCHI A , Benchimol EI, Bernstein CN, Bitton A, et al
    Inflammatory bowel disease: A Canadian burden of illness review.
    Can J Gastroenterol. 2012;26:811-7.
    PubMed     Text format     Abstract available


  13. RAZIK R , Bernstein CN, Sam J, Thanabalan R, et al
    Survey of perceptions and practices among Canadian gastroenterologists regarding the prevention of venous thromboembolism for hospitalized inflammatory bowel disease patients.
    Can J Gastroenterol. 2012;26:795-8.
    PubMed     Text format     Abstract available


    October 2012
  14. REZAIE A , Quan H, Fedorak RN, Panaccione R, et al
    Development and validation of an administrative case definition for inflammatory bowel diseases.
    Can J Gastroenterol. 2012;26:711-7.
    PubMed     Text format     Abstract available


    September 2012
  15. STOJANCEVIC M , Stankov K, Mikov M
    The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.
    Can J Gastroenterol. 2012;26:631-7.
    PubMed     Text format     Abstract available


  16. NARULA N , Dhillon A, Chauhan U, Marshall J, et al
    An audit of influenza vaccination status in adults with inflammatory bowel disease.
    Can J Gastroenterol. 2012;26:593-6.
    PubMed     Text format     Abstract available


    August 2012
  17. WONG S , Walker JR, Carr R, Graff LA, et al
    The information needs and preferences of persons with longstanding inflammatory bowel disease.
    Can J Gastroenterol. 2012;26:525-31.
    PubMed     Text format     Abstract available


    December 2011
  18. TABRY H , Farrands PA
    Update on anal fistulae: surgical perspectives for the gastroenterologist.
    Can J Gastroenterol. 2011;25:675-80.
    PubMed     Text format     Abstract available


  19. SOKOLLIK C , Ang M, Jones N
    Autophagy: a primer for the gastroenterologist/hepatologist.
    Can J Gastroenterol. 2011;25:667-74.
    PubMed     Text format     Abstract available


    October 2011
  20. JONES J , Panaccione R, Russell ML, Hilsden R, et al
    Medical management of inflammatory bowel disease among Canadian gastroenterologists.
    Can J Gastroenterol. 2011;25:565-9.
    PubMed     Text format     Abstract available


    September 2011
  21. QIN X
    What made Canada become a country with the highest incidence of inflammatory bowel disease: Could sucralose be the culprit?
    Can J Gastroenterol. 2011;25:511.
    PubMed     Text format    


  22. LOOMES DE , Teshima C, Jacobs P, Fedorak RN, et al
    Health care resource use and costs in Crohn's disease before and after infliximab therapy.
    Can J Gastroenterol. 2011;25:497-502.
    PubMed     Text format     Abstract available


  23. BINION DG , Louis E, Oldenburg B, Mulani P, et al
    Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.
    Can J Gastroenterol. 2011;25:492-6.
    PubMed     Text format     Abstract available


    August 2011
  24. PANACCIONE R , Loftus EV Jr, Binion D, McHugh K, et al
    Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.
    Can J Gastroenterol. 2011;25:419-25.
    PubMed     Text format     Abstract available


  25. COTE-DAIGNEAULT J , Bernard EJ
    Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.
    Can J Gastroenterol. 2011;25:417-8.
    PubMed     Text format    


  26. GHOSH S
    Estimating benefits of therapy in Crohn's disease in terms of indirect costs.
    Can J Gastroenterol. 2011;25:412.
    PubMed     Text format    


    July 2011
  27. SCHICHO R , Storr M
    Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
    Can J Gastroenterol. 2011;25:377-83.
    PubMed     Text format     Abstract available


    June 2011
  28. KUENSTNER JT
    Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: Controversy resolution requires the patient perspective, not the clinician perspective.
    Can J Gastroenterol. 2011;25:297-8.
    PubMed     Text format    


    May 2011
  29. BERNSTEIN CN , El-Gabalawy H, Sargent M, Landers C, et al
    Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.
    Can J Gastroenterol. 2011;25:269-73.
    PubMed     Text format     Abstract available


    March 2011
  30. BOROWIEC AM , Fedorak RN
    Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.
    Can J Gastroenterol. 2011;25:140-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: